# DESCRIPTION

## TECHNICAL FIELD

- define technical field

## BACKGROUND

- motivate liquid biopsies
- introduce extracellular vesicles
- describe structure of EV
- discuss role of EV in cancer
- limitations of current EV research
- need for biological reference material

## DETAILED DESCRIPTION

- introduce recombinant extracellular vesicles (rEV) as biological reference material
- describe rEV composition: self-assembling protein and heterologous marker
- explain physical and biochemical characteristics of rEV
- compare rEV with endogenous sample EV
- describe method to determine recovery rate of sample EV
- outline method steps: mixing, isolating, detecting, and determining recovery rate
- define "sample extracellular vesicle (sample EV)"
- define "endogenous EV"
- define "heterologous marker"
- describe examples of heterologous markers
- describe method with heterologous nucleic acid molecule or protein
- describe method with fused heterologous protein
- describe method with fused heterologous nucleic acid
- outline detecting step: determining amount of heterologous nucleic acid
- describe examples of detecting techniques
- describe preferred embodiment: light-emitting protein or mRNA
- define "self-assembling protein"
- describe examples of self-assembling proteins
- describe method with chosen self-assembling protein
- define "biofluid sample"
- describe examples of biofluid samples
- describe method with plasma or serum sample
- outline isolation step: any type of isolation method
- describe detecting step: quantifying rEV
- describe examples of detecting techniques
- describe method with separation step
- describe separation step: density-based separation
- describe detecting step: detecting rEV in first fraction
- describe examples of detecting techniques
- describe method with additional biophysical isolation step
- describe examples of biophysical isolation steps
- describe method with size exclusion chromatography
- describe detecting step: detecting rEV in first fraction
- describe examples of detecting techniques
- describe method with protease treatment
- describe method with lipid conjugated PEG
- describe method with immune precipitation
- describe method with incubation with immunoglobulin proteins
- describe method to calibrate device for sample EV analysis
- outline calibration method steps: mixing, introducing, analyzing, and deriving
- define "to calibrate"
- define "fluid"
- define "optionally"
- define "a property"
- describe examples of analyzing a property
- define "device settings"
- describe examples of devices to be calibrated
- describe method to evaluate EV isolation
- outline evaluation method steps: mixing, isolating, and detecting

### EXAMPLES

- list antibodies used for immunostaining
- describe cell culture and transfection conditions
- outline rEV isolation procedure
- describe cell viability measurement
- detail Optiprep density gradient ultracentrifugation
- outline sample collection from patients
- describe EV isolation from plasma
- detail differential ultracentrifugation
- outline size exclusion chromatography
- describe additional purification steps
- outline ExoQuick-TC protocol
- describe immune electron microscopy
- outline Nano particle tracking analysis
- describe high resolution flow cytometry
- detail zeta potential measurements
- outline rEV quantification via fluorescence intensity measurement
- describe rEV quantification via anti-P24 ELISA
- outline protein analysis
- describe protein concentration measurement
- outline protein analysis by SDS-PAGE and Western blot
- describe LC-MS/MS analysis
- outline data analysis for LC-MS/MS
- describe immune precipitation
- outline RNA analysis
- describe RNA isolation
- outline RT-qPCR analysis
- describe lipid analysis
- outline lipid extraction
- describe ESI-MS/MS analysis
- outline cholesterol measurement
- describe rEV PEGylation
- outline lyophilization procedure
- describe freezing and storage conditions
- outline quality control measures
- describe data analysis and interpretation
- outline statistical analysis
- describe data visualization
- summarize results

### Example 1: Recombinant Extracellular Vesicles (rEV) Share Physical and Biochemical Characteristics with Endogenous Sample Extracellular Vesicles (Sample EV)

- produce rEV
- isolate rEV by ODG and pelleting
- analyze transfection efficiency
- compare physical characteristics of rEV and MOCK EV
- analyze biochemical characteristics of rEV and MOCK EV
- identify EV-enriched proteins in rEV and MOCK EV
- analyze lipid composition of rEV and MOCK EV
- compare cholesterol concentration of rEV and MOCK EV
- summarize similarities between rEV and MOCK EV

### Example 2: Identification of rEV Detection Methods

- identify rEV by fluorescent NTA
- identify rEV by high resolution flow cytometry
- identify rEV by Western blot and ELISA

### Example 3: Identification of Optimized Storage Conditions of rEV

- analyze stability of rEV under different storage conditions
- identify optimal storage conditions for rEV

### Example 4: The Use of rEV to Estimate the Efficiency of EV Isolation Methods

- spike rEV in PBS or plasma
- perform SEC, dUC, Exoquick precipitation, and ODG
- evaluate recovery of rEV by Western blot and fNTA
- analyze elution profiles of rEV and sample EV
- quantify rEV by fNTA and anti-P24 ELISA
- analyze aggregation of rEV in plasma
- perform ODG on urine spiked with rEV
- analyze effect of proteinase K treatment on rEV
- summarize efficiency of EV isolation methods

### Example 5: rEV Allows for an Accurate Comparison of EV Numbers in Plasma from Cancer Patients Versus Healthy Individuals

- spike rEV in plasma from cancer patients and healthy individuals
- quantify EV and rEV by NTA and fNTA, respectively

### Example 6: Implementing the PSI Sequence to Load EGFP mRNA in rEV

- modify pMET7-GAG-EGFP plasmid with PSI sequence to load EGFP mRNA in rEV

